Researchers found that tirzepatide or Mounjaro reduced A1C levels by 2% to 2.3%, while Ozempic (1 mg) led to a 1.9% reduction
In an interview with the Associated Press , 38-year-old Danielle Griffin said that although she was able to get a prescription for Novo Nordisks weight loss shot Wegovy and even got it covered by her insurance, which is still often a struggle the medication just didnt work for her
Side Effects Both medications can cause: Nausea Constipation Reflux Fatigue in the beginning Tirzepatide may cause a bit more nausea for some people, but it also seems to be better tolerated in others
By activating GLP-1 receptors, semaglutide helps reduce hunger signals in the brain, slows digestion, and promotes a feeling of fullness after meals
Wegovy has a retail price of around $1,350 for a four-week supply.[3] Insurance coverage varies widely, and many insurance plans do not cover medications for obesity.[4] Supply shortages have also affected access to GLP-1 medications